To read more on this topic click here.
MJFF announces $10 million competition for Parkinson’s
Author: Simge Eva DoganPublished: 26 September 2019
Prep: Cook: Serves:
The Michael J Fox Foundation has launched the ‘Ken Griffin Alpha-synuclein Imaging Competition’ – a US $10 million programme aiming to develop a game-changing tool for Parkinson’s research.
As part of the competition, participating teams will compete in a scientific race to build a device that is able to identify alpha-synuclein – a protein closely associated with Parkinson’s. Although almost everyone diagnosed with Parkinson’s has clumps of alpha-synuclein in the brain, these are currently only visible when analysing tissue during autopsies.
The competition is named after Ken Griffin, CEO of US investment firm Citadel who has given US $7.5 million funding to the programme.
Griffin – whose father has Parkinson’s – said: “If we have the imaging capability to observe the pathology that arises from protein-misfolding in real time, and understand how drugs are impacting people in real time, that would be a major advance.”
Share this story
Reaching the rural areas of Pakistan with specialised care
Extending knowledge and resources to all corners of the countryREAD MORE
Australian Prime Minister backs #UniteForParkinsons as campaign goes viral
Hashtag trending on Twitter on World Parkinson’s DayREAD MORE
Can a diabetes drug be repurposed to treat Parkinson’s too?
Common diabetes drug may have potential to treat Parkinson’sREAD MORE